万维提示：
1、投稿方式：在线投稿。
2、刊内网址：
http://www.maternal-fetalmedicine.org（202302期）
自动跳转至：
https://journals.lww.com/mfm/pages/default.aspx
3、投稿系统：
https://www.editorialmanager.com/mfm/default.aspx
4、中华医学会期刊主页：
https://mednexus.org/journal/mfm
（从中华医学期刊网https://www.medjournals.cn进入）
5、出刊日期：季刊，逢季首月25日出版。
2023年7月28日星期五
《母胎医学杂志（英文）》投稿须知
【官网信息】
投稿须知：https://edmgr.ovid.com/mfm/accounts/ifauth.htm
INSTRUCTIONS FOR AUTHORS
The Editorial Office is pleased to answer any questions you may have about preparing your manuscript in accordance with the guidelines.
E-mail: mfm@cmaph.org, mfmedicine@126.com
AIMS AND SCOPE
Maternal-Fetal Medicine (MFM) is a newly launched international peer-reviewed journal of the Chinese Medical Association. The aim of the journal is to publish high quality scientific articles in all areas of Obstetrics and Maternal-Fetal Medicine, including original clinical and translational research, state-of-the-art reviews, commentaries, case studies and case reports, and letters to the editor. Articles are published quarterly. The journal is available both in print and online.
Areas covered include but not limited to:
Medical complications of pregnancy
Adverse events of pregnancy
Fetal development
Prenatal screening and diagnosis
Fetal Treatment and Therapy
Technology and developments in the field of Obstetrics and Maternal-Fetal Medicine
ONLINE SUBMISSION
All manuscripts must be submitted online through the website:
https://www.editorialmanager.com/mfm
First-time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. Authors do not have to pay for submission of articles. If you experience any problems, please contact the editorial office by E-mail: mfm@cmaph.org; mfmedicine@126.com.
JOURNAL POLICIES
DUPLICATE PUBLICATION
Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to MFM and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The Editorial team may subject any manuscript submitted for consideration of publication in MFM to plagiarism-detection software.
This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication.
DISCLOSURE OF CONFLICTS
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:" For example: “Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X - the CME organizers for Company A. For the remaining authors, no relevant conflicts of interest were declared.”
Financial Support and Competing Interests
A financial disclosure section is part of the submission process and must be completed by each author at submission. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.
The primary purpose of the disclosure section is to determine whether authors have received any commercial financial support that could create a conflict of interest. In addition to monetary interests, a potential for conflict of interest can exist whether or not an individual believes that a relationship (such as dual commitments, competing interests, or competing loyalties) affects his or her scientific judgment. Please review ICMJE Uniform Requirements for Manuscripts.
AUTHORSHIP
MFM expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall provide the data. Each author’s specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include:
Participated in research design
Participated in the writing of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration.
RETRACTION POLICY
MFM should consider retracting a publication if:
Editors have clear evidence that the findings are unreliable, either as a result of misconduct (e.g., data fabrication) or honest error (e.g., miscalculation or experimental error).
The findings have previously been published elsewhere without proper crossreferencing, permission or justification (i.e., cases of redundant publication).
It constitutes plagiarism.
It reports unethical research.
MFM abides by Retraction Guidelines of the Committee on Publication Ethics (COPE) (http://publicationethics.org/files/retraction%20guidelines_0.pdf).
等等……
